Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM)
CUSIP: 00534B100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 21,148,193
- Total 13F shares
- 11,882,184
- Share change
- +289,153
- Total reported value
- $14,927,921
- Price per share
- $1.30
- Number of holders
- 13
- Value change
- +$160,006
- Number of buys
- 8
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 00534B100?
CUSIP 00534B100 identifies ADGM - Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00534B100:
Top shareholders of ADGM - Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
46%
|
9,812,419
|
$7,898,997 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
7.2%
|
1,200,000
|
$1,656,000 | $0 | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
3.3%
|
700,000
|
$563,430 | — | 31 Mar 2025 | |
| Shaolin Capital Management LLC |
13F
|
Company |
1.2%
|
260,000
|
$209,273 | — | 31 Mar 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1%
|
213,235
|
$169,543 | — | 31 Mar 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.99%
|
209,361
|
$168,515 | — | 31 Mar 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
0.52%
|
110,571
|
$92,106 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.47%
|
100,000
|
$79,510 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.36%
|
76,757
|
$61,782 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
36,799
|
$29,258 | — | 31 Mar 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0.15%
|
30,875
|
$24,549 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
28,877
|
$22,960 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.05%
|
11,435
|
$9,092 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,670
|
$2,149 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
197
|
$159 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
32
|
$26 | — | 31 Mar 2025 | |
| James L. Cox |
3/4/5
|
Director |
—
mixed-class rows
|
400,698
mixed-class rows
|
— | — | 20 Mar 2025 | |
| Orly Mishan |
3/4/5
|
Director |
—
class O/S missing
|
300,000
|
— | — | 20 Mar 2025 | |
| Olav Bergheim |
3/4/5
|
CEO, Director |
—
class O/S missing
|
234,134
|
— | — | 31 Jul 2024 | |
| Keyvan Mirsaeedi-Farahani |
3/4/5
|
Director |
—
class O/S missing
|
90,000
|
— | — | 20 Mar 2025 | |
| Sandra A. Gardiner |
3/4/5
|
Director |
—
class O/S missing
|
90,000
|
— | — | 20 Mar 2025 | |
| Timothy P. Moran |
3/4/5
|
Director |
—
class O/S missing
|
90,000
|
— | — | 20 Mar 2025 | |
| Hakon Bergheim |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
8,539
mixed-class rows
|
— | — | 31 Jul 2024 |
Institutional Holders of Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM) as of Q2 2025
As of 30 Jun 2025,
Adagio Medical Holdings, Inc. - Common Stock, par value $0.0001 per share (ADGM) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,882,184 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Shaolin Capital Management LLC, RTW INVESTMENTS, LP, Opaleye Management Inc., Affinity Asset Advisors, LLC, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, TORONTO DOMINION BANK, and UBS Group AG.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
14
Q2 2025 holders
13
Holder diff
-1
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.